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Abstract
A previous study showed that a plasmid expressing IFNa (pIFNa) strongly enhanced protec-
tion and antibody production of a DNA vaccine against infectious salmon anemia virus
(ISAV) in Atlantic salmon. The vaccine consisted of a plasmid (pHE) expressing the virus
hemagglutinin-esterase as an antigen. To increase the understanding of the adjuvant effect
of pIFNa, we here compared transcriptome responses in salmon muscle at the injection site
at week 1 and 2 after injection of pIFNa, pHE, plasmid control (pcDNA3.3) and PBS, respec-
tively. The results showed that the IFNa plasmid mediates an increase in gene transcripts of
at least three major types in the muscle; typical IFN-I induced genes (ISGs), certain chemo-
kines and markers of B- cells, T-cells and antigen-presenting cells. The latter suggests
recruitment of cells to the plasmid injection site. Attraction of lymphocytes was likely caused
by the induction of chemokines homologous to mammalian CCL5, CCL8, CCL19 and
CXCL10. IFN may possibly also co-stimulate activation of lymphocytes as suggested by
studies in mammals. A major finding was that both pcDNA3.3 and pHE caused responses
similar to pIFNa, but at lower magnitude. Plasmid DNA may thus by itself have adjuvant
activity as observed in mammalian models. Notably, pHE had a lower effect on many
immune genes including ISGs and chemokines than pcDNA3.3, which suggests an inhibi-
tory effect of HE expression on the immune genes. This hypothesis was supported by an
Mx-reporter assay. The present study thus suggests that a main role for pIFNa as adjuvant
in the DNA vaccine against ISAV may be to overcome the inhibitory effect of HE- expression
on plasmid-induced ISGs and chemokines.
Introduction
A previous study showed that Atlantic salmon type I interferons (IFNs) possess potent adju-
vant effect in combination with a DNA vaccine against infectious salmon anemia virus (ISAV)
based on the viral hemagglutinin-esterase (HE) as antigen [1]. Vaccination of salmon with a
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plasmid expressing HE (pHE) alone gave low antibody titres and a minor protection against
ISAV. In contrast, pHE injected together with a plasmid expressing IFNa (pIFNa) gave high
levels of IgM antibodies against ISAV and strong protection against ISAV-infection. This dem-
onstrated that type I IFNs enhance adaptive immune responses in Atlantic salmon against the
HE antigen of ISAV and thus function as adjuvants. It is known from mammalian studies that
recombinant type I IFNs stimulate adaptive immune responses against protein antigens and
that the mechanism involves direct stimulation of B-cells, T-cells and dendritic cells (DCs) [2–
4]. The protective effects of DNA vaccines against the salmonid rhabdoviruses IHNV and
VHSV are also associated with induction of type I IFN stimulated genes (ISGs), but in those
studies the effects of antigens could not be dissected from the IFN-inducing activity [5–7]. A
benefit of the IFN adjuvanted DNA vaccine against ISAV is that effects of the virus antigen HE
and type I IFN can be assessed separately. To increase the understanding of the adjuvant effect
of salmon type I IFN, we in the present work did a comparative transcriptome analysis of mus-
cle tissue at the injection site of presmolts at one and two weeks after injection of pIFNa, pHE,
plasmid without insert (pcDNA3.3) or PBS. The importance of muscle tissue for the adaptive
immune response is underlined by the fact that the adjuvant effect of the IFNa plasmid must
be caused by stimulation of immune cells at the muscle injection site since IFNa does not
induce antiviral genes systemically in salmon [1, 8]. Moreover, while antigen-presenting cells
play a critical role in DNA vaccination of mammals, transfected muscle cells are important for
the magnitude and duration of the induced immune response [9]. An essential question in the
present work was how pHE influenced expression of immune related genes. Expectedly,
pIFNa induced high transcript levels of a multitude of genes including a panel of typical ISGs.
In addition, pIFNa strongly enhanced transcripts of B- and T-cell markers suggesting attrac-
tion of lymphocytes to the site of plasmid injection. Surprisingly, both pcDNA3.3 and pHE
caused similar responses as pIFNa although at a lower magnitude. However, the level of tran-
scripts from several immune genes induced by pHE was lower compared to pcDNA3.3, which




All handling of fish was performed in accordance to the Norwegian “Regulation on Animal
Experimentation” and all fish experiments were submitted to and approved by the Norwegian
Animal Research Authority (NARA) before initiation.
Fish
Atlantic salmon (Salmo salar L.) presmolts (30–40 g) of the strain Aquagen standard (Aqua-
gen, Kyrksæterøra, Norway) were kept in 300 L tanks supplied with fresh water at 10˚C and
were fed commercial dry food in Tromsø Aquaculture Research Station, Norway. For injection
of plasmids, fish were anesthetized with 0.005% benzocaine (ACD Pharmaceuticals, Norway)
and different groups were labeled by tattooing (2% alcian blue, Panjet inoculator). Before har-
vest, fish were euthanized by an overdose of benzocaine (0.01%).
Treatment of fish with plasmids
pcDNA3.3 encoding the open reading frame (ORF) of Atlantic salmon IFNa1 (pIFNa) and
pcDNA3.3 plasmid without insert were available from a previous study [10]. pcDNA3.3
encoding hemagglutinin-esterase from infectious salmon anemia virus was obtained by
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subcloning from a construct used previously and is named pHE [1]. The plasmids were puri-
fied by EndoFree plasmid purification kit from Qiagen.
Presmolt salmon were injected intramuscularly (i.m.) approximately 1 cm below the dorsal
fin with 15 μg plasmids in 50 μl sterile phosphate-buffered saline (PBS) at pH 7.4 or with PBS
only. Fish groups (N = 5) included non-treated fish (Group 1) and fish injected with PBS
(Group 2), pcDNA3.3 (Group 3), pIFNa (Group 4) and pHE (Group 5). Muscle at the injection
site was sampled at one week (W1) and two weeks (W2) after injection and used for RNA
isolation.
Gene expression analysis by reverse transcription quantitative PCR
(qPCR)
Muscle samples from the injection site were homogenized using TissueLyser II (QIAGEN) (30
sec, 30 1/s) and total RNA was extracted using the RNeasy1 Mini Kit (Qiagen). RNA (500 ng
in a 20 μl reaction) was reverse transcribed using high capacity cDNA Reverse Transcription
kit (Applied Biosystems). cDNA was diluted 10 times and 5 μl of cDNA was used per 20 μl
PCR reaction, which also included primers for target gene (0.25 μM) and Fast SYBR1 Green
Master Mix (Applied Biosystems). The samples were applied in duplicates and the measure-
ment was done using ABI Prism 7500 FAST Cycler from Applied Biosystems (initial denatur-
ation 95˚C: 20s and 40 cycles of 95˚C: 3s, and 60˚C: 30s). Primer sequences are included in S1
Table. Expression of each gene was calculated relative to Elongation factor1αβ (EF1αβ)
as0020described [11]. In S2 Table, expression values were normalized against the levels of
EF1αβ and fold change in expression of different genes was calculated against that of PBS
group using the method described by Pfaffl [12]. Unpaired t-test with two-tail distribution was
used for statistical analysis, p 0.05.
Microarray analyses
Nofima’s Atlantic salmon oligonucleotide microarray SIQ-6 (GEO Accession no. GPL16555)
was produced by Agilent Technologies in the 15 K x 8 format, all reagents and equipment
were from the same source [13]. Analyses included five groups, four individuals per time-
point; totally forty arrays were used. Total RNA (200 ng per reaction) was labelled with Cy3
using Low Input Quick Amp Labeling Kit and fragmented with Gene Expression Hybridiza-
tion Kit. Hybridization was performed for 17 hours in an oven at 65˚C at rotation speed of 10
rounds per minute. Arrays were washed for one minute with Gene Expression Wash Buffer I
at room temperature, and one minute with Gene Expression Wash Buffer II at 37˚C and
scanned. Data analyses were carried out with Nofima’s bioinformatics package [13]. Global
Normalization was performed by equalizing the mean intensities of all microarrays. Next, the
individual values for each feature were divided to the mean value of all samples producing
expression ratios (ER). The log2-ER were calculated and normalized with the locally weighted
non-linear regression (Lowess). The data are presented as ratios to PBS injected control plas-
mid injected groups. Differentially expressed genes were selected by criteria: p< 0.05 and
log2-ER > |0.8| (1.74-fold). The microarray data presented in this publication has been depos-
ited in the NCBI´s Gene Expression Omnibus (GEO, https://www.ncbi.nlm.nih.gov/geo/) and
is available under the accession number GSE106111.
Reporter gene assay
The reporter plasmid pGL3-Basic-PrMx1 containing the rainbow trout Mx1 promoter fused
to the firefly luciferase gene was obtained from Dr. Bertrand Collet, FRS Marine Laboratory,
Aberdeen [14]. Renilla luciferase construct was purchased from Sabiosciences. A plasmid
Transcriptome analysis of ISAV DNA vaccine with IFN as adjuvant
PLOS ONE | https://doi.org/10.1371/journal.pone.0188456 November 21, 2017 3 / 20
expressing EGFP (pEGFP) was obtained from Invitrogen and a plasmid expressing ovalbumin
(pOVA) was constructed with the open reading frame of the chicken ovalbumin gene (Acc.
Nr. NP_990483) inserted downstream of CMV promoter in the pcDNA3.3 vector. CHSE-214
cells were seeded in 48-well plate (80,000 cells/well) and chemically transfected (Lipofectamin
2000, Thermo Fisher) with 250 ng/well of either pcDNA3.3, pHE, pEGFP or pOVA in combi-
nation with 90 ng/well constitutively expressing Renilla luciferase construct (SABiosciences)
and 250 ng/well of pGL3-Basic-PrMx1. Cells were stimulated for 24 hours with 1000 U/ml
salmon IFNa or left un-stimulated. Twenty four hours post stimulation cells were lysed in
20 μl lysis buffer and 10 μl was used for the luciferase luminescence assays using the Dual-
Luciferase1 Reporter Assay System (Promega). The luminescence from both firefly and
Renilla luciferase was measured using a plate luminometer, Luminoskan Ascent (Thermo Sci-
entific, Beverly, MA), and result are presented as Relative Light Units. Each experiment was set
up in six parallels, three wells were stimulated with IFNa and three wells were left un-stimu-
lated. Unpaired t-test with two-tail distribution was used for statistical analysis, p 0.05.
Results
Summary of transcriptome responses
The number of differentially expressed genes (DEG) increased from week 1 (W1) to week 2
(W2) in all the three groups of fish injected with plasmid (Fig 1A). The magnitude of responses
was consistently greatest in pIFNa group (Fig 1B). Gene expression changes in response to the
control plasmid and pIFNa were highly correlated being greater in the latter group (Fig 1C).
The virus protein HE modulated responses to plasmid: 98 genes showed difference between
pcDNA3.3 and pHE and 61 of these had lower expression in pHE group. A significant fraction
of DEGs is involved in immune responses and most of them were up-regulated by all three
plasmids.
Genes involved in innate antiviral immunity
IFNs. Expression of IFNa, IFNb, IFNc and IFN-gamma (IFNg) in muscle were studied by
qPCR (Fig 2). Expression of all genes are compared to PBS unless stated otherwise.
Compared to non-treated fish (NO-INJ), injection of PBS caused a minor, but non-signifi-
cant down-regulation of these genes, except for IFNg at W2. As expected, IFNa expression in
fish injected with pIFNa was highest (mean fold increase of 114 times at W1 and 72 times at
W2). IFNa transcripts showed an increase in fish injected with pcDNA3.3 at W1 and a larger
Fig 1. An overview of transcriptome responses to plasmids at the injection sites of skeletal muscles. A: numbers of differentially expressed
genes (DEG). B: magnitude of differentially expression assessed as sum of log2 (expression ratio-ER) to PBS injected fish for 3670 DEG. C:
relationship of transcriptome responses to pIFNa (y-axis) and pcDNA3.3 (x-axis). Data are log2(ER) at W2.
https://doi.org/10.1371/journal.pone.0188456.g001
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increase at W2, but the differences were not statistically significant. pHE gave a small increase
in IFNa transcripts at W1 and no increase at W2. Expression of IFNb was significantly up-reg-
ulated only by pIFNa at W1. The plasmids did apparently not have any effect on IFNc expres-
sion. IFNg expression was significantly enhanced by pIFNa at W1, but not at W2. pcDNA3.3
gave significantly increased IFNg expression at W1, but decreased expression at W2. pHE did
not have any significant effect on IFNg expression at any time point. Compared to pcDNA3.3,
pHE showed lower expression of IFNa, IFNb, IFNc and IFNg, but the differences between the
two groups were not significant.
Fig 2. Expression of Type I and Type II IFN in response to plasmids at the injection site. Groups of fish
(N = 5) were injected with PBS, pcDNA3.3, pHE or pIFNa, or kept non-treated (NO-INJ). RNA was isolated
from muscle at the injection site at one (W1) and two (W2) weeks post injection and expression of different
IFN genes was measured by qPCR. Data are presented as mean gene expression relative to expression of
EF1αβ +/- SD. Bars not sharing common letter are significantly different (p 0.05).
https://doi.org/10.1371/journal.pone.0188456.g002
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Interferon stimulated genes (ISGs). Many genes revealed up-regulated by the plasmids
with microarrays and qPCR were previously identified as ISGs in Atlantic salmon TO cells
[15] and as virus responsive genes (VRGs) in a transcriptome survey of salmon infected with
different RNA viruses [16], totally 125 features. ISGs have crucial roles in innate antiviral
immunity. Several ISGs such as Mx, ISG15 and viperin, possess direct antiviral activity, some
are involved in virus recognition (RIG-I, LGP2) and some are transcription factors involved in
IFN induction or IFN signalling (IRFs, STATs), while the functions of others are less known.
As expected, pIFNa caused strong up-regulation of antiviral ISGs both in the microarray (Fig
3A) and qPCR analyses (Fig 3B). The microarray analyses showed that all three plasmids
induced multiple other genes with various functions. In all cases the responses were strongest
with pIFNa and in most cases weakest with pHE. The strongest responses were detected for
Very large inducible GTPase, TRIM16 and 25 as well as Receptor transporting protein 3 and
RIG-I like receptor LGP2. The overall response to pIFNa detected by microarray analysis was
similar or higher at W2 compared to W1. pcDNA3.3 also up-regulated these genes, but at a
substantially lower level than pIFNa. The response to pHE was lower compared to pcDNA3.3
at W1, but the difference had levelled off at W2.
IRFs and STATs have important roles in induction of IFN and/or ISGs. The microarray
analysis showed highest up-regulation of IRF1, IRF2, IRF3, IRF5, IRF7 and IRF8 by pIFNa,
lower for pcDNA3.3, and in most cases lowest for pHE (Panel A in S1 Fig). Similar profiles
were seen for STAT1, STAT2 and STAT3. In contrast, STAT3-like protein and STAT5b were
down-regulated by all three plasmids at both W1 and W2 while IRF7 was down-regulated by
pHE at W2. As with ISGs, pIFN caused highest responses and pHE the lowest. Similar patterns
of expression were observed by qPCR analysis (Panel B in S1 Fig). Expression of IRF1, IRF3,
IRF7 as well as STAT1 and STAT2 were significantly up-regulated by pIFNa. Overall,
pcDNA3.3 showed a higher stimulatory effect than pHE at both time points, which was statis-
tically significant for IRF3, IRF7, STAT1 and STAT2 at W1.
Genes involved in inflammation
Injection of plasmids caused a strong inflammation, which was observed as red coloration at
the injection site. The microarray data showed that expression of several pro-inflammatory
chemokines and chemokine receptors were significantly influenced by plasmid injection (Fig
4A). All three plasmids stimulated expression of one CCL5-like gene, one CCL8-like gene, and
two CCL19-like genes. In contrast, a CXCL14-like gene was down-regulated by all three plas-
mids. pIFNa had the strongest stimulatory effect on the chemokines and most prominently
enhanced transcription of the CCL5-like gene at both time points. For CCL5 and most of the
other genes, the response was strongest at W2 in the pIFNa group. Of chemokine receptor
genes, the plasmids enhanced expression of two CCR3-like genes, one CCR7-like, one
CCR9-like and one CXCR3-like gene. Similar to chemokines, pIFNa showed the strongest
effect with the exception of CCR7, which had higher expression in response to pcDNA3.3 at
W1. pcDNA3.3 and pHE showed small differences in stimulatory effect on chemokines and
receptors except that pcDNA3.3 caused stronger enhancement of CCR7-like transcripts at
both W1 and W2. The microarray data were supported by qPCR analysis for the CCL5-,
CCL19- CXCL10- and CCR9-like genes despite large individual differences (Fig 4B). Among
interleukins, only IL-16 and IL-18 were up-regulated by the plasmids and the responses were
modest. On the other hand, the microarray data showed that several cytokine receptors were
strongly up-regulated by pIFNa at both W1 and W2 with IL10Rb and CRFB3 showing the
strongest responses (Fig 4A). These receptors were also up-regulated by pcDNA3.3 and pHE
to similar levels except CRFB3, which at W2 had lower expression with pHE compared to
Transcriptome analysis of ISAV DNA vaccine with IFN as adjuvant
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pcDNA3.3. The microarray data showed that pHE induced more strongly MMP9 and SAA5
than pcDNA3.3, two inflammatory effectors that commonly exhibit strong responses in Atlan-
tic salmon [17].
Fig 3. Expression of genes involved in innate antiviral responses. A. Microarray data of IFN stimulated
genes (ISGs). Numbers represent fold changes compared to the PBS group in this and subsequent
microarray figures, and expression difference (> 1.74-fold, p < 0.06) is indicated with underlined italics.
Symbols * and ¤ after gene names denote difference (same criteria) respectively between pIFNa and
pcDNA3.3 and between pcDNA3.3 and pHE. B. qPCR of selected antiviral ISGs. The primers for Mx
recognize both salmon Mx1 and Mx3. Groups of fish (N = 5) were injected with PBS, pcDNA3.3, pHE or
pIFNa, or kept non-treated (NO-INJ). Data are presented as mean gene expression relative to expression of
EF1αβ +/- SD. Bars not sharing common letter are significantly different (p 0.05).
https://doi.org/10.1371/journal.pone.0188456.g003
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Fig 4. Inflammatory responses. A. Microarray data of chemokines, cytokines and their receptors and
effectors. Data produced and presented as for Fig 3. B. Expression of chemokines in response to plasmids
measured by qPCR. Treatment groups and sampling for RNA extraction as described in Fig 3. Data are
presented as mean gene expression relative to expression of EF1αβ +/- SD, bars not sharing common letter
are significantly different p 0.05).
https://doi.org/10.1371/journal.pone.0188456.g004
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Genes involved in adaptive immune responses
Attraction of B-cells and T-cells. B-cells play an important role not only in antibody pro-
duction, but also in antigen presentation. The most important markers of B-cells are immuno-
globulins (Ig). The microarray data showed enhanced expression of IgM heavy chain and Ig
light chains in response to all three plasmids, where the magnitude of response decreased in
the range pIFNa>pcDNA3.3>pHE (Fig 5A). The qPCR results showed significant up-regula-
tion of IgM isoforms, IgD, IgT and Ig light chain in the pIFNa group compared to PBS at both
time-points (Fig 5B). The difference between pIFN and pHE was also significant at both time
points except for IgD at W2. The difference between pIFNa and pcDNA3.3 was statistically
significant for all genes at W1 except for IgT and Ig light chain, while at W2 there were no sig-
nificant differences between the two groups. Expression of several of the Igs was higher in
response to pcDNA3.3 than to pHE, but the difference was statistically significant only for Ig
light chain (Fig 5B). Interestingly, both the microarray and the qPCR data showed that
pcDNA3.3 and pIFNa enhanced strong and similar expression of the preB cell receptor Ig
lambda-like polypeptide 1 (IGLL1). While the microarray data showed that pHE only caused a
minor up-regulation of this gene (Fig 5A), the qPCR data showed no significant difference in
IGLL1 expression between pcDNA3.3 and pHE (Fig 5B). Microarrays also showed that the
plasmids increased abundance of transcripts from a suite of genes that control differentiation
and signalling of B-cells including tyrosine kinase BTK, tyrosine kinase SYK, hematopoietic
adaptor protein NASH1 and B-cell linker protein BLNK (Fig 5A).
T-cells include CD4+ helper cells (Th1) and CD8+ cytotoxic cells (CTL), which play key
roles in humoral and cell mediated adaptive immunity, respectively. The common markers for
T-cells are T cell receptors (TCR) alpha and TCRbeta chains, while their co-receptors CD4
and CD8 are major markers for helper and cytotoxic T cells respectively. CTLs also produce
granzyme and perforin while both cell types produce IFNg. The TCR is associated with
CD3epsilon, CD3delta, CD3gamma and CD3zeta (CD247) molecules in both cell types. Tele-
ost fish possess CD3gammadelta, which is assumed to be the ancestor of CD3delta and
CD3gamma [18]. Most T-cells also contain CD28, which is important for T-cell activation by
interacting CD80/CD86 on APCs. The microarray data showed a strong stimulatory effect of
pIFN on expression of the TCRalpha and TCRbeta chains, particularly at W2 (Fig 6A).
Responses were lower to pcDNA3.3 compared to pIFNa. In general, the strongest responses
were detected in the pIFNa and pcDNA3.3 groups, while pHE gave the weakest responses.
Expression of other T-cell markers (CD3, CD28, CD274, SYK, Plastin, SH2D2A) followed a
similar pattern of response to plasmids with pIFNa>pcDNA3.3>pHE (Fig 6A). qPCR analysis
showed the same expression profile as the microarray analysis (Fig 6B). pIFNa showed the
strongest response and increased the expression of TCRbeta, CD274, CD4, CD8a, CD45,
CD83 and Granzyme K compared to PBS at both time points. pcDNA3.3 and pHE also aug-
mented expression of these genes, and again the effect of pcDNA3.3 was stronger than pHE.
This difference was statistically significant for TCRβ, CD83 at W1, and for Granzyme K at
both time points. Taken together, the microarray and qPCR data showed that the plasmids
caused enhanced expression of marker genes for B-cells and T-cells, which indicated attraction
of lymphocytes to the injection sites. pIFNa caused highest expression of lymphocyte markers
while pHE caused lowest expression.
Antigen presentation. Immune cells such as dendritic cells, B cells and macrophages are
involved in antigen presentation. This process includes uptake/infection, proteasomal or endo-
somal degradation and presentation of antigen peptides by MHC-I or MHC-II molecules on
the cell surface. MHC-I present antigenic peptides to cytotoxic T-cells while MHC-II present
peptides to T-helper cells. Most cells express MHC-I, which is up-regulated by IFN due to the
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presence of ISRE elements in the promoter [19]. In contrast, MHC-II is expressed constitu-
tively in antigen-presenting cells (APCs), though may be up-regulated by IFNg in some other
Fig 5. Expression of B cell marker genes. A. Microarray results. Data produced and presented as
explained for Fig 3. B. Expression of immunoglobulins in response to plasmids measured by qPCR.
Treatment groups and sampling for RNA extraction as described in Fig 3. Data are presented as mean gene
expression relative to expression of EF1αβ +/- SD, bars not sharing common letter are significantly different
p 0.05).
https://doi.org/10.1371/journal.pone.0188456.g005
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cell types [20, 21]. Presentation of antigen peptides by MHC-I occurs in infected cells after
digestion of the antigen by the immunoproteasome, transportation of peptides into ER by the
TAP glycoprotein followed by loading antigenic peptides onto MHC-I molecules mediated by
tapasin and other chaperone molecules [22]. APCs use MHC-II to present peptide fragments
from extracellular antigens, which are taken up by endocytosis or exocytosis and are digested
in endosomes.
Fig 6. Expression of T cell marker genes. A. Microarray results. Data produced and presented as
explained for Fig 3. B. Expression of T-cell markers in response to plasmids measured by qPCR. Treatment
groups and sampling for RNA extraction as described in Fig 3. Data are presented as mean gene expression
relative to expression of EF1αβ +/- SD, bars not sharing common letter are significantly different p 0.05).
https://doi.org/10.1371/journal.pone.0188456.g006
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In the microarray study, all three plasmids up-regulated expression of genes associated with
the MHC-I pathway including MHC-I antigen, beta-microglobulin, TAP and genes related to
the proteasome complex with strongest stimulation at W2 (Fig 7A). pIFNa had the strongest
stimulatory effect at both time points while the difference between pcDNA3.3 and pHE was
minimal. The above pattern of expression was confirmed by qPCR of MHC-I, PSMB7 and
PSMB9 except that pcDNA3.3 showed higher levels of expression for these genes compared to
pHE (Fig 7B). The difference in expression was significant for MHC-I and PSMB9, which thus
seemed to be inhibited by pHE. The plasmids also caused up-regulation of MHC-II with the
highest responses at W2, which was significant for pIFNa compared to PBS. However, neither
microarray nor qPCR analyses showed significant differences in expression of MHC-II
between the plasmids.
Inhibition of IFNa signalling by pHE studied by Mx reporter assay
ISGs typically possess ISRE motifs in their promoters as described for Mx, ISG15 and viperin
[23–25]. Both the microarray and qPCR analyses showed a stimulatory effect of pcDNA3.3 on
the interferon system while the effect of pHE was lower. A reporter assay based on salmon
Mx1 promoter was used to examine the effect of these plasmids on activation of the Mx1 pro-
moter (Fig 8). Effects of plasmids expressing ovalbumin (pOVA) and EGFP (pEGFP) were
also studied to examine if expression of foreign proteins in general would influence IFN signal-
ling. CHSE 214 cells were transfected with three expression constructs, a plasmid containing
the Mx1 promoter fused to the firefly luciferase gene; pHE, pOVA, pEGFP or pcDNA3.3; and
a plasmid expressing the Renilla luciferase gene as a transfection control. Twenty-four hours
later, three wells from each treatment were stimulated with 1000 U/ml IFNa and three wells
were left without stimulation. All cells were harvested 24 h after stimulation and analysed for
luciferase activity (Fig 8). The data showed similar Mx promoter activity in cells transfected
with pcDNA3.3 and pEGFP and slightly lower activity in pOVA treated cells. In contrast, the
Mx promoter activity was 3.8-fold lower in pHE treated cells than in pcDNA3.3 treated cells.
Since pHE has a pcDNA3.3 backbone, the result indicates an inhibitory effect of HE expression
on Mx promoter activity.
Discussion
The present gene expression analyses were conducted to throw light on the adjuvant mecha-
nisms of pIFNa in the DNA vaccine against ISAV in Atlantic salmon. The results from both
microarrays and qPCR demonstrated that pIFNa mediates an increase in gene transcripts
encoding proteins of four major functional types in the muscle: typical IFN induced proteins
(ISGs), which are important in innate antiviral immunity; certain chemokines; markers of B-
and T-lymphocytes attracted to the site of injection and proteins involved in antigen presenta-
tion. The results thus confirmed and extended qPCR results from our previous study [1].
Changes of transcripts abundance detected with microarrays and qPCR takes place through
several processes: responses to plasmid DNA, responses to IFNa transcribed from pIFNa, tran-
scripts of attracted leukocytes and modulation of these processes by HE in cells that have taken
up pHE. As discussed below, attraction of lymphocytes is likely caused by the induction of che-
mokines by IFNa and plasmid DNA. The action of IFNa is most likely mainly accomplished
by signalling through the Jak/STAT pathway. This results in activation of ISGs, which possess
ISRE elements in their promoters such as the antiviral genes Mx, ISG15 and viperin [23–25].
The present study revealed that pIFNa induced these and a multitude of other genes involved
in innate antiviral immunity. Chemokines may, however, be induced by other mechanisms
than ISGs as discussed below for CXCL10. In mammals, adjuvant activity of type I IFNs has
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Fig 7. Expression of genes involved in antigen presentation. A. Microarray results. Data produced and
presented as explained for Fig 3. B. Expression of genes involved in antigen presentation in response to
plasmids measured by qPCR. Treatment groups and sampling for RNA extraction as described in Fig 3. Data
are presented as mean gene expression relative to expression of EF1αβ +/- SD, bars not sharing common
letter are significantly different p 0.05).
https://doi.org/10.1371/journal.pone.0188456.g007
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been explained by its direct stimulatory effect on B-cells, T-cells and DCs [2–4]. The adjuvant
effect of pIFNa in salmon may thus have a dual effect, firstly by attracting lymphocytes and sec-
ondly by contributing to their activation.
Two other important findings were made in this work. The first was that both the control
plasmid pcDNA3.3 and pHE enhanced transcript levels of similar genes as pIFN, but to a
lower extent. Plasmid DNA may thus up-regulate these genes directly or via IFNa. pcDNA3.3
did not induce IFNa, IFNb or IFNc at W1, but did induce IFNa at W2. However, plasmid
DNA may also induce IFNs at earlier time points after injection, but this was not measured.
The plasmid pcDNA3.1 was found to have similar effects on transcription of IFNa and ISGs in
the muscle of rainbow trout [7]. Taken together, plasmid DNA may by itself have adjuvant
activity as observed in mammalian models [26, 27].
The other major finding was that pHE had a lower effect on expression of many immune
genes including ISGs and chemokines compared to pcDNA3.3, which suggests that expression
of HE inhibited induction of ISGs by plasmid DNA. This hypothesis was supported by the
Mx-reporter assay, which showed that Mx promoter activity was significantly lower in cells
transfected with pHE than in cells transfected with pcDNA3.3 alone or cells transfected with
plasmids expressing ovalbumin or EGFP (Fig 8). Whether the inhibition is caused by overex-
pression of HE or by antagonistic activity of HE on IFN signalling, needs to be examined in
future studies. It can, however, not be excluded that HE also inhibits IFN induction. Taken
together, the present study suggests that the main role of pIFNa as adjuvant in the DNA vac-
cine against ISAV is that it has a much stronger ability to attract and stimulate immune cells at
the injection site than pHE alone.
Fig 8. Effect on IFNa signaling of plasmids expressing HE, ovalbumin or EGFP measured by Mx
reporter assay. CHSE cells were transfected with three expression constructs, a plasmid containing the Mx1
promoter fused to the firefly luciferase gene; a plasmid expressing either HE (pHE), ovalbumin (pOVA) or
EGFP (pEGFP) or pcDNA3.3 (vector control); and a plasmid expressing the Renilla luciferase gene as a
transfection control. Twentyfour hours after transfection, 3 wells from each treatment were stimulated for 24
hours with 1000 U/ml IFNa1 (B) and 3 wells were left untreated (A). Cells were then harvested and measured
for luciferase activity. Results are presented as mean Relative Light Units (RLU) calculated by dividing
blanked firefly luciferase values to blanked Renilla luciferase. Significant differences from treatment with
pcDNA3.3 are indicated by * (p<0.05), ** (p<0.01), ***(p<0.001), ****(p<0.0001).
https://doi.org/10.1371/journal.pone.0188456.g008
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Attraction of B- and T-cells and the role of chemokines
All three plasmids increased transcripts for markers of B-cells (IgM, Ig light chain) and T-cells
(TCR, CD8) as discussed in more detail below. For several of these genes, the effect of pIFNa
was higher than pcDNA3.3 at W1, while for some of the genes the differences levelled off at
W2. This supports that plasmid DNA induces type I IFN, which affects genes at W2. Notably,
pHE showed lower enhancement of B- and T-cell markers than pcDNA3.3, especially at W2.
Accordingly, pHE does thus not seem to attract lymphocytes at the same level as pIFN or even
pcDNA3.3.
An increase in transcripts of secreted IgM was observed in all three plasmid groups, which
suggests attraction of B-cells that produce natural antibodies. Such cells are associated with the
early innate immune response to pathogens. All three plasmids gave increased transcripts of
membrane-bound IgM (mIgM), which suggests increased attraction of B-cells associated with
adaptive immunity. mIgM expression was highest at W2, indicating increase with time after
injection. Expression of mIgM was significantly lower in response to pHE compared to
pcDNA3.3 at W2.
Attracted T-cells are likely to be a mixture of helper T-cells and CTLs as seen by increased
transcripts of CD4, CD8 and granzyme K. However, CD4 and CD8 are also expressed in other
cell types. A number of other genes associated with leukocytes were increased by injection of
pIFNa, but the data were not sufficient for identification of other cell types.
Attraction of lymphocytes was likely due to induction of chemokines by plasmid DNA and
IFNa. All three plasmids significantly increased transcripts of chemokines homologous to
mammalian CCL5, CCL8 and CCL19, and chemokine receptors homologous to mammalian
CCR3, CCR7, CCR9 and CXCR3. While pIFNa had the strongest effect, the differences were
not significant between the pcDNA3.3 and pHE groups. The salmon CCL5-like genes belong
to the macrophage inflammatory protein (MIP) group of CC-chemokines, CCL8 belongs to
the monocyte chemotactic protein (MCP) group and CCL19 belongs to the CCL19/21/25
group [28]. In mammals, CCL5 has specificity for CCR1 and CCR5 and attracts T-cells and
monocytes [29]. Salmon CCL5s phylogenetically group with the rainbow trout chemokine
CK5B, which has been shown to attract B-cells [28, 30]. Mammalian CCL8 has specificity for
CCR1, CCR2 and CCR5 and attracts many different immune cells [28, 31, 32]. Mammalian
CCL19 is a ligand for CCR7, which primarily promotes homing of T cells and DCs to T cell
areas of lymphoid tissues where T cell priming occurs [33]. Interestingly, rainbow trout CCR7
is present on a subpopulation of IgD+IgM- B-cells, which indicates that salmon CCL19 also
may attract such cells [34].
The qPCR data showed up-regulation of CXCL10 by all three plasmids at W1. CXCL10 is
strongly induced by IFNg both in mammals and Atlantic salmon [35, 36]. In contrast to
recombinant IFNg, recombinant IFNa had little effect on transcription of CXCL10 in Atlantic
salmon TO cells [36]. Increased levels of CXCL10-like transcripts at the injection site may thus
result from increased synthesis of IFNg either due to induction by plasmid DNA or IFNa or
due to attracted IFNg expressing cells. The only cellular receptor for CXCL10 identified to
date is CXCR3, which is associated with CD4+ Type -1 helper (Th1) and CD8+ cytotoxic T-
cells (CTLs), but is also expressed on natural killer cells, plasmacytoid dendritic cells and sub-
sets of B-cells [35]. However, in the present work we did not observe increased expression of
CXCR3 in response to the plasmids.
A recent study identified 48 chemokine-receptors in Atlantic salmon, but their ligand speci-
ficities are not yet known [37]. However, salmon CCR7, CCR9 and CXCR4 showed unambig-
uous homology with their human counterparts while homology between salmon and
mammalian CCR3 were less convincing. In mammals, CCR3 is a receptor for multiple
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chemokines and is expressed on eosinophils, basophiles, mast cells, platelets and Th2 cells;
CCR7 is a receptor for CCL19 and CCL21 and is expressed on T-cells and dendritic cells;
CCR9 is a receptor for CCL25 and is selectively expressed on T-cells in the thymus and small
intestine [32, 38, 39].
Taken together, injection of plasmids might attract T-cells due to induction of CXCL10-
and CCL19-like chemokines. It is as yet uncertain which chemokines that cause attraction of
B-cells. However, pIFNa induced CCL5, which is related to trout chemokine CK5B that
showed attraction for B-cells [30].
Antigen presentation
Activation of Th1 and CTLs are dependent on presentation of peptide fragments by MHC II
and MHC I, respectively. This normally occurs in professional antigen presenting cells
(APCs), but it has been proposed that muscle cells also might conduct these tasks [9, 40]. The
present study showed that pIFNa increased MHC I transcription, which is in agreement with
the effect of recombinant IFNa on Atlantic salmon TO cells [15]. IFNa-mediated increase of
MHC-I transcription is likely due to the presence of ISRE elements in the MHC-I promoter
[41]. The IFNa mediated increase in MHC-I transcription was accompanied by an increase in
transcripts of several members in the MHC-I antigen presentation pathway such as tapasin,
TAP and members of the immunoproteasome complex (PSMB6-PSMB9) (Fig 7). It remains
unknown whether this occurred in muscle cells or professional APCs. Both pcDNA3.3 and
pHE also up-regulated these genes and the response was higher at W2 compared to W1. The
qPCR data showed that pHE seemed to have down-regulated expression of MHC-I and
PSMB9 at W1 (Fig 7B).
In contrast to MHC-I, MHC-II lacks IFN-I stimulatory elements in its promoter and is typ-
ically expressed constitutively on professional APCs [42]. The microarray analyses showed
that all three plasmids gave an increase in MHC-II transcripts at W2 where pIFNa gave the
strongest response. This suggests that IFNa mediates attraction of APCs. The increase in
MHC-II transcripts was less clear in the qPCR analyses. Whether this is due to allelic variations
is not known at the present.
Induction of genes by pIFNa compared to DNA vaccines against fish
rhabdoviruses
The DNA vaccines against the salmonid rhabdoviruses VHSV and IHNV are plasmids
expressing the virus G-protein as antigen and have both been shown to induce IFNa and/or
ISGs in the muscle [7, 43]. Accordingly, IFNa has been suspected to play a role in the superior
protective effect of these vaccines and the present work supports this idea. The plasmid
expressing the IHNV G protein (pIHNw-G) strongly augmented transcripts of genes associ-
ated with adaptive immunity similar to pIFNa in the present study [7]. This suggests that
pIFNa and pIHNw-G have in common the ability to attract B- and T-cells to the injection site
and to increase MHC-I mediated presentation of antigen. More recently, the DNA vaccine
against VHSV based on the G-protein as antigen (pVHSV) was shown to promote recruitment
of B cells to the muscle injection site [30]. Recruitment of lymphocytes to the vaccine injection
site is associated with induction of chemokines both by pIFNa and the DNA vaccines against
IHNV and VHSV. Common for all three plasmids is that they induce chemokines homologous
to the mammalian CXCL9, CXCL10 and CXCL11, which are all induced by IFNg. However,
while pIFNa most strongly induced a CXCL10-like chemokine, pVHSV and pIHNw-G
induced a CXCL11-like chemokine [7, 30]. In addition, pIFNa was found to induce CCL8-
and CCL19- like genes, which apparently has not been reported in the VHSV/IHNV DNA
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vaccine studies. In the VHSV DNA vaccine work, expression of 12 different chemokines was
studied [30]. In addition to the CXCL11-like chemokine, pVHSV was only found to enhance
transcripts of the chemokine CK5B, which groups with mammalian CCL4/CCL5 and the che-
mokine CK6, which groups with mammalian CCL17/CCL22 [30]. Trout CK5B and CK6
showed chemotactic properties for B-cells and were suggested to cause recruitment of B-cells
to the injection site of the VHSV DNA vaccine [30]. In the present study, pIFNa was found to
enhance expression of a CCL5-like protein, which showed strong homology with trout CK5B.
On the other hand, pIFNa had little effect on expression of the salmon CK6-like gene.
Conclusion
The adjuvant effect of pIFNa in the DNA vaccine against ISAV appears to result from recruit-
ment and possibly stimulation of B-cells, T-cells and antigen presenting cells. Plasmid DNA is
likely to also possess adjuvant activity since pcDNA3.3 increased transcripts of a similar set of
genes as pIFNa, but at a lower level. The finding that pHE showed lower enhancement of ISGs
and chemokine expression than pcDNA3.3, suggests that expression of HE inhibits induction
of genes induced by plasmid DNA. A main function of pIFNa as adjuvant in the DNA vaccine
against ISAV may thus be to overcome the inhibitory action of HE on expression of ISGs.
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